id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-D-0094-0034,FDA,FDA-2002-D-0094,"Guidance for the Public, Food and Drug Administration Advisory
Committee Members, and Food and Drug Administration Staff: Public
Availability of Advisory Committee Members’ Financial Interest
Information and Waivers",Other,Guidance,2014-03-31T04:00:00Z,2014,3,2014-03-31T04:00:00Z,,2024-11-07T23:07:11Z,,1,0,0900006481691d05
FDA-2002-D-0094-0033,FDA,FDA-2002-D-0094,"Guidance for the Public, Food and Drug Administration Advisory
Committee Members, and Food and Drug Administration Staff: Public
Availability of Advisory Committee Members’ Financial Interest
Information and Waivers; Availability",Notice,Notice of Availability,2014-03-31T04:00:00Z,2014,3,2014-03-31T04:00:00Z,,2014-03-31T14:12:23Z,2014-06997,0,0,09000064816912ef